"The results for tolerability, safety, and the immune response to the vaccine candidate are very promising," explains Prof Marylyn Addo. The antibodies which developed against the virus were still ...

The MERS coronavirus—MERS stands for “Middle East Respiratory Syndrome”—causes severe respiratory diseases with a high mortality rate. To date, there is neither a vaccine nor a specific treatment. The ...

Five outstanding researchers were elected to the Executive Board at the general meeting of the German Center for Infection Research (DZIF). Prof. Dirk Busch, Prof. Andreas Peschel, and Prof. Thomas ...

The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe. The safety of the tested vaccine ...